Elhízás: vizsgálatok itt: Lengyelország
63 trials · From ClinicalTrials.gov and EU CTIS (euclinicaltrials.eu), checked 2026. november 10.. Ask the study team whether a trial fits you.
- 3. fázisTaking peopleA Clinical Study to Evaluate the Effects of Enicepatide (RO7795068) in Participants With Obesity or Overweight Without Type 2 Diabetes
- Where
- Bialystok, Bydgoszcz, Cracow, Gdynia, Lublin, Opole, Tarnów, Tychy, Warsaw, Zamość
- Életkor
- 18 év and over
- People
- 2000 worldwide
- Run by
- Hoffmann-La Roche
See details and how to joinNCT07351045 · EU 2025-523104-71-00 - 3. fázisTaking peopleA Clinical Study to Evaluate the Effects of Enicepatide (RO7795068) in Participants With Obesity or Overweight and Type 2 Diabetes
- Where
- Białystok, Bydgoszcz, Debica, Lublin, Pabianice, Poznan, Ruda Śląska, Siedlce, Warsaw, Wroclaw
- Életkor
- 18 év and over
- People
- 1600 worldwide
- Run by
- Hoffmann-La Roche
See details and how to joinNCT07351058 · EU 2025-523106-32-00 - 3. fázisTaking peopleA Study to Learn About the Study Medicine Called Berobenatide (PF-08653944) in People With Overweight or Obesity
- Where
- Gdansk, Lublin, Poznan, Wrocław, ZDROWIE OSTEO-MEDIC S.C. L. i A. Racewicz, A. i J. Supronik
- Életkor
- 18 év and over
- People
- 954 worldwide
- Run by
- Pfizer
See details and how to joinNCT07595549 · EU 2026-525318-75-00 - 3. fázisTaking peopleA Phase III Study to Evaluate the Efficacy and Safety of Petrelintide in Participants With Overweight or Obesity and Type 2 Diabetes
- Where
- Bialystok, Cracow, Mazowieckie, Warsaw
- Életkor
- 18 év and over
- People
- 600 worldwide
- Run by
- Hoffmann-La Roche
See details and how to joinNCT07843485 · EU 2026-526189-25-00 - 3. fázisNot yet taking people in LengyelországA Research Study to Investigate How Well the Medicine CagriSema Lowers High Blood Pressure in People Living With High Blood Pressure and Obesity
- Where
- Elblag, Gdansk, Gdynia, Grodzisk Mazowiecki, Krakow, Lodz, Ostrów Mazowiecka, Rzeszów, Siedlce, Starachowice, Świnoujście, Warsaw
- Életkor
- 18 év and over
- People
- 1408 worldwide
- Run by
- Novo Nordisk A/S
See details and how to joinNCT07919405 - 3. fázisTaking peopleA Platform Trial for Pediatric Participants With Obesity or Overweight (LY900040)
- Where
- Krakow, Lodz, Rzeszów, Stanisławów Pierwszy, Warsaw, Wroclaw
- Életkor
- 6 év to 17 év
- People
- 125 worldwide
- Run by
- Eli Lilly and Company
See details and how to joinNCT06672549 - 3. fázisTaking peopleA Study of Orforglipron (LY3502970) in Adolescent Participants With Obesity, or Overweight With Related Comorbidities
- Where
- Cracow, Warsaw, Wroclaw
- Életkor
- 12 év to 17 év
- People
- 150 worldwide
- Run by
- Eli Lilly and Company
See details and how to joinNCT06672939 · EU 2024-514081-40-00 - 2. fázisTaking peopleA Study of LY3457263 Compared With Placebo in Participants With Type 2 Diabetes on a Stable Dose of Semaglutide or Tirzepatide
- Where
- Bialystok, Cracow, Gdansk, Lodz, Lublin, Tarnów, Warsaw, Warszawa, Wroclaw
- Életkor
- 18 év to 75 év
- People
- 200 worldwide
- Run by
- Eli Lilly and Company
See details and how to joinNCT06897475 · EU 2024-520328-27-00 - 3. fázisTaking peopleMirikizumab Administered at the Same Time as Tirzepatide in Adult Participants With Moderately to Severely Active Ulcerative Colitis and Obesity or Overweight: Phase 3b Study
- Where
- Katowice, Opole, Piotrkow Trybunalski, Poznan, Rzeszów, Szczecin, Warsaw, Wroclaw, Zamość
- Életkor
- 18 év to 70 év
- People
- 350 worldwide
- Run by
- Eli Lilly and Company
See details and how to joinNCT06937086 · EU 2024-520209-38-00 - 3. fázisTaking peopleMirikizumab and Tirzepatide Administered in Adult Participants With Moderately to Severely Active Crohn's Disease and Obesity or Overweight
- Where
- Lublin, Opole, Piotrkow Trybunalski, Poznan, Rzeszów, Szczecin, Warsaw, Wroclaw, Zamość
- Életkor
- 18 év to 70 év
- People
- 290 worldwide
- Run by
- Eli Lilly and Company
See details and how to joinNCT06937099 · EU 2024-520210-21-00 - 3. fázisTaking peopleA Study of Orforglipron in Female Participants With Stress Urinary Incontinence Who Have Obesity or Overweight
- Where
- Bydgoszcz, Skorzewo, Szczecin, Warsaw, Wroclaw
- Életkor
- 18 év and over
- People
- 1000 worldwide
- Run by
- Eli Lilly and Company
See details and how to joinNCT07202884 · EU 2025-522514-23-00 - 3. fázisTaking peopleA Study of Eloralintide (LY3841136) in Participants With Obesity or Overweight, and Type 2 Diabetes
- Where
- Bialystok, Bydgoszcz, Cracow, Elblag, Lodz, Lublin, Ruda Śląska, Zabrze
- Életkor
- 18 év and over
- People
- 1035 worldwide
- Run by
- Eli Lilly and Company
See details and how to joinNCT07282600 · EU 2025-523658-15-00 - 3. fázisTaking peopleEfficacy, Safety, and Pharmacokinetics of Tirzepatide (LY3298176) Once Weekly Versus Placebo in Pediatric Participants 6 to Less Than 12 Years of Age Who Have Obesity (ADVANCE-SURMOUNT-KIDS)
- Where
- Lodz, Rzeszów, Stanisławów Pierwszy, Warsaw, Warszewo, Wroclaw
- Életkor
- 6 év to 11 év
- People
- 150 worldwide
- Run by
- Eli Lilly and Company
See details and how to joinNCT07817875 · EU 2025-522020-27-00 - No phaseTaking peopleAsprosin and miRNA Expression in Young Women With Metabolic Syndrome
- Where
- Nowy Targ
- Életkor
- 18 év to 35 év
- People
- 110
- Run by
- University of Applied Sciences in Nowy Targ
See details and how to joinNCT07917364 - 3. fázisNot yet taking people in LengyelországA Study of Eloralintide (LY3841136) in Participants With Obesity or Overweight, Type 2 Diabetes, and Increased Cardiovascular Risk
- Where
- Bialystok, Białystok, Krakow, Kraków, Lublin, Piotrkow Trybunalski
- Életkor
- 45 év to 64 év
- People
- 3000 worldwide
- Run by
- Eli Lilly and Company
See details and how to joinNCT07900633 · EU 2026-525919-14-00 - 3. fázisTaking peopleMaridebart Cafraglutide versus Placebo in Adult Participants with Obstructive Sleep Apnea not on Positive Airway Pressure Therapy (MARITIME-OSA-2)
- Where
- Bialystok, Poznan, Warsaw
- Életkor
- 18 év and over
- People
- 120 worldwide
- Run by
- Amgen Inc.
See details and how to join2025-522699-94-00 · EU 2025-522699-94-00 - 3. fázisTaking peopleA Study to Evaluate Effect of AZD6234 in Adult Participants With Obesity or Overweight With Weight-related Comorbidity Without Type 2 Diabetes Mellitus
- Where
- Bialystok, Cracow, Elblag, Gdynia, Katowice, Legnica, Lodz, Poznan, Radzionkow, Warsaw, Wroclaw
- Életkor
- 18 év and over
- People
- 2500 worldwide
- Run by
- AstraZeneca
See details and how to joinNCT07784725 · EU 2025-523379-41-00 - 3. fázisTaking peopleEfficacy and Safety of Once-Daily Oral ASC30 Compared with Placebo in Participants with Obesity or Overweight with Weight-Related Comorbidities
- Where
- Biała Podlaska, Bydgoszcz, Cracow, Czestochowa, Gdansk, Gdynia, Katowice, Krakow, Lodz, Łódź, Lublin, Poznan, Pulawy, Siedlce, Staszow, Torun, Warsaw, Warszawa, Wroclaw, Wrocław
- Életkor
- 18 év and over
- People
- 932 worldwide
- Run by
- Ascletis Pharma (China) Co. Ltd.
See details and how to join2026-526172-23-00 · EU 2026-526172-23-00 - 3. fázisTaking peopleMaridebart Cafraglutide in Heart Failure With Preserved or Mildly Reduced Ejection Fraction and Obesity
- Where
- Bialystok, Bydgoszcz, Chrzanów, Elblag, Gdansk, Gdynia, Giżycko, Katowice, Krakow, Lodz, Lublin, Miechów, Olsztyn, Oświęcim, Rzeszów, Skierniewice, Skorzewo, Torun, Tychy, Warsaw, Wroclaw, Żarów
- Életkor
- 18 év to 99 év
- People
- 5056 worldwide
- Run by
- Amgen
See details and how to joinNCT07037459 - 3. fázisTaking peopleA Study to Evaluate Effect of AZD6234 in Adult Participants With Type 2 Diabetes Mellitus and Obesity or Overweight
- Where
- Bialystok, Elblag, Gdynia, Katowice, Krakow, Legnica, Lodz, Poznan, Radzionków, Warsaw, Wroclaw
- Életkor
- 18 év and over
- People
- 1500 worldwide
- Run by
- AstraZeneca
See details and how to joinNCT07784270 - 3. fázisTaking peopleMaridebart Cafraglutide in Heart Failure With Preserved or Mildly Reduced Ejection Fraction and Obesity (MARITIME-HF)
- Where
- Bialystok, Białystok, Bydgoszcz, Chrzanów, Cracow, Elblag, Gdansk, Gdynia, Gizycko, Katowice, Lodz, Lublin, Miechów, Olsztyn, Ostrów Mazowiecka, Oswiecim, Rzeszow, Skierniewice, Skorzewo, Torun, Tychy, Warsaw, Warszawa, Wroclaw, Żarów
- Életkor
- 18 év and over
- People
- 2787 worldwide
- Run by
- Amgen Inc.
See details and how to join2024-516654-22-00 · EU 2024-516654-22-00 - 3. fázisNot yet taking people in LengyelországEfficacy And Safety of Olatorepatide in Adults With Overweight or Obesity Without Diabetes
- Where
- Bialystok, Bydgoszcz, Cracow, Gdansk, Gdynia, Ilawa, Lublin, Myslowice, Poznan, Rzeszow, Siedlce, Swidnica, Warsaw, Warszawa, Wroclaw
- Életkor
- 18 év and over
- People
- 3000 worldwide
- Run by
- Regeneron Pharmaceuticals
See details and how to joinNCT07896265 · EU 2025-524861-26-00 - No phaseCsak meghívásosBiałystok PLUS - Polish Longitudinal University Study
- Where
- Bialystok
- Életkor
- 20 év to 80 év
- People
- 8320
- Run by
- Medical University of Bialystok
See details and how to joinNCT03197363 - 3. fázisTaking peopleEfficacy and Safety of Once-Daily Oral ASC30 Compared with Placebo in Participants with Obesity or Overweight with Type 2 Diabetes Mellitus
- Where
- Biała Podlaska, Bydgoszcz, Cracow, Czestochowa, Gdansk, Gdynia, Katowice, Krakow, Lodz, Łódź, Lublin, Poznan, Pulawy, Siedlce, Staszow, Torun, Warsaw, Warszawa, Wroclaw, Wrocław
- Életkor
- 18 év and over
- People
- 549 worldwide
- Run by
- Ascletis Pharma (China) Co. Ltd.
See details and how to join2026-526336-39-00 · EU 2026-526336-39-00 - 3. fázisTaking peopleA Master Protocol to Investigate Efficacy and Safety of Elecoglipron in Participants With Obesity or Overweight With or Without T2DM
- Where
- Bialystok, Bydgoszcz, Kielce, Krakow, Lodz, Lublin, Poznan, Radom, Warsaw
- Életkor
- 18 év and over
- People
- 4500 worldwide
- Run by
- AstraZeneca
See details and how to joinNCT07667803